A new strategy to attack aggressive brain cancer shrank tumors in two early tests
WASHINGTON — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, … Read more
/cdn.vox-cdn.com/uploads/chorus_asset/file/25456835/DSC07518.JPG)